SCHEMBL775632

SCHEMBL775632

CCC(C)(C)SSC(C)(C)CC

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15848918 0.89 TSHR (0.35) TSHRTDP1
SCHEMBL7556770 0.85 TSHR (0.38) TSHRTDP1
SCHEMBL16472483 0.82
SCHEMBL23140218 0.80
SCHEMBL23140232 0.76
SCHEMBL775427 0.75 TSHR (0.43) TSHRTDP1ALDH1A1
SCHEMBL19865538 0.75 TSHR (0.30) TSHRTDP1
SCHEMBL23186661 0.75 TSHR (0.30) TSHRTDP1
SCHEMBL19322393 0.75
SCHEMBL19387294 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552997-B2 Targeted disulfide reduction in petroleum matrices CHEVRON U.S.A. INC. (US) 2026-02-17 US claimed
EP-4733356-A1 METHACRYLIC RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED BODY Kuraray Co., Ltd. (JP) 2026-04-29 EP disclosed
EP-4733334-A1 METHACRYLIC RESIN AND METHOD FOR PRODUCING SAME, METHACRYLIC RESIN COMPOSITION, AND MOLDED BODY Kuraray Co., Ltd. (JP) 2026-04-29 EP disclosed
US-12573655-B2 Lithium-sulfur secondary battery LG ENERGY SOLUTION, LTD. (KR) 2026-03-10 US disclosed
US-12552997-B2 Targeted disulfide reduction in petroleum matrices CHEVRON U.S.A. INC. (US) 2026-02-17 US disclosed
WO-2025009543-A1 PHOTOSENSITIVE COMPOSITION, METHOD FOR PRODUCING CURED FILM, PARTITION WALL, LIGHT-EMITTING ELEMENT, AND DISPLAY DEVICE セントラル硝子株式会社 2025-01-09 WO disclosed
CN-113692666-B Lithium sulfur secondary battery 株式会社LG新能源 2024-11-05 CN disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
CN-118240128-A Method for preparing a composition comprising a copolymer of methyl methacrylate and methacrylic acid 盛禧奥欧洲有限责任公司 2024-06-25 CN disclosed
WO-2024097698-A1 TARGETED DISULFIDE REDUCTION IN PETROLEUM MATRICES CHEVRON U.S.A. INC. (US) 2024-05-10 WO disclosed
EP-1737876-B1 AVERMECTIN AND AVERMECTIN MONOSACCHARIDE SUBSTITUTED IN THE 4\"-AND 4'-POSITION RESPECTIVELY SYNGENTA PARTICIPATIONS AG (CH) 2009-08-05 EP disclosed
US-20090064585-A1 ODORISATION OF FUEL GAS WITH LOW-SULFUR ODORANTS SYMRISE GMBH & CO. KG (DE) 2009-03-12 US disclosed
EP-2012386-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2009-01-07 EP disclosed
US-20080051353-A1 Avermectin And Avermectin Monosaccharide Substituted In The 4\"- And 4\" Position Respectively SYNGENTA CROP PROTECTION, INC. (US) 2008-02-28 US disclosed
EP-1737876-A1 AVERMECTIN AND AVERMECTIN MONOSACCHARIDE SUBSTITUTED IN THE 4\"-AND 4'-POSITION RESPECTIVELY Syngenta Participations AG (CH) 2007-01-03 EP disclosed
WO-2005097816-A1 AVERMECTIN AND AVERMECTIN MONOSACCHARIDE SUBSTITUTED IN THE 4”- AND 4’- POSITION RESPECTIVELY SYNGENTA PARTICIPATIONS AG (CH) 2005-10-20 WO disclosed
US-6617392-B2 Alkene or acetylene polymerization inhibitor selected from sulfure, disulfide having formula R'-S-S-R''(R' AND R''are monovalent or divalent hydrocarbon radical), organic tin containing sulfur YANG WEN-CHEN (TW) 2003-09-09 US disclosed
US-20020086943-A1 Molding composition of siloxane capable of extending mold lifetime YANG WEN-CHEN (TW) 2002-07-04 US disclosed
US-6008376-A Aminohydroxylation of olefins with tert-alkyl sulfonamides THE SCRIPPS RESEARCH INSTITUTE (US) 1999-12-28 US disclosed
US-4425258-A Catalysts for polymerization of olefins DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1984-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12573655-B2 Lithium-sulfur secondary battery HCN2, HCN4, CACNA1F TSHR 2670/4885TDP1 3952/4885ALDH1A1 3543/4885
US-20080051353-A1 Avermectin And Avermectin Monosaccharide Substituted In The 4\"- And 4\" Position Respectively CCR6, CHRM4, CHRM5 TSHR 256/4885TDP1 2843/4885ALDH1A1 3420/4885
US-12552997-B2 Targeted disulfide reduction in petroleum matrices DDHD2, ATP2A2, ORAI1 TSHR 4643/4885TDP1 4682/4885ALDH1A1 584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.